AGCC vs STZ vs BEAM vs MGPI vs WDFC

For growth investors, Agencia Comercial Spirits Ltd (AGCC) is the stronger pick with 186.

0% revenue growth year-over-year, versus -23. 8% for MGP Ingredients, Inc. (MGPI). WD-40 Company (WDFC) offers the better valuation at 30. 6x trailing P/E (34. 2x forward), making it the more compelling value choice. Analysts rate Constellation Brands, Inc. (STZ) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, MGP Ingredients, Inc.

is actually cheaper at 11. 4x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Agencia Comercial Spirits Ltd (AGCC) delivered a total return of +218.

3%, compared to -66. 6% for MGP Ingredients, Inc. (MGPI). Over 10 years, the gap is even starker: AGCC returned +218. 3% versus MGPI's -15. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), WD-40 Company (WDFC) is the lower-risk stock at 0.

19β versus Beam Therapeutics Inc. 's 2. 08β — meaning BEAM is approximately 978% more volatile than WDFC relative to the S&P 500. On balance sheet safety, Agencia Comercial Spirits Ltd (AGCC) carries a lower debt/equity ratio of 7% versus 170% for Constellation Brands, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Agencia Comercial Spirits Ltd (AGCC) is pulling ahead at 186.

0% versus -23. 8% for MGP Ingredients, Inc. (MGPI). On earnings-per-share growth, the picture is similar: Beam Therapeutics Inc. grew EPS 82. 3% year-over-year, compared to -419. 9% for MGP Ingredients, Inc.. Over a 3-year CAGR, BEAM leads at 31. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Agencia Comercial Spirits Ltd (AGCC) is the more profitable company, earning 30.

7% net margin versus -57. 2% for Beam Therapeutics Inc. — meaning it keeps 30. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AGCC leads at 40. 0% versus -274. 6% for BEAM. At the gross margin level — before operating expenses — BEAM leads at 84. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, MGP Ingredients, Inc.

(MGPI) trades at 11. 4x forward P/E versus 34. 2x for WD-40 Company — 22. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MGPI: 58. 6% to $29. 00.

In this comparison, STZ (2.

8% yield), MGPI (2. 6% yield), WDFC (1. 8% yield) pay a dividend. AGCC, BEAM do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, WD-40 Company (WDFC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

19), 1. 8% yield, +114. 5% 10Y return). Beam Therapeutics Inc. (BEAM) carries a higher beta of 2. 08 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (WDFC: +114. 5%, BEAM: +68. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (AGCC (Consumer Defensive) and STZ (Consumer Defensive) and BEAM (Healthcare) and MGPI (Consumer Defensive) and WDFC (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: AGCC is a small-cap high-growth stock; STZ is a mid-cap quality compounder stock; BEAM is a small-cap high-growth stock; MGPI is a small-cap quality compounder stock; WDFC is a small-cap quality compounder stock. STZ, MGPI, WDFC pay a dividend while AGCC, BEAM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.